Streetbeat News

PYNKF

Perimeter Medical Imaging AI Inc

Industry

Dimension Stone Mining and Quarrying

Open

0.27

Mkt cap

24M

Volume

High

0.27

P/E Ratio

-1.13

52-wk high

1.00

Low

0.27

Div yield

N/A

52-wk low

0.22

Perimeter Medical Imaging AI's B-Series OCT with ImgAssist AI 2.0 has shown superior results in a clinical trial for breast-conserving surgeries, meeting primary endpoints with significant reduction in residual cancer. The company plans to submit an FDA PMA application in early 2025.

Portfolio Pulse from

November 20, 2024 | 9:15 pm

Perimeter Medical Imaging AI, Inc. (PYNKF) held its Q3 2024 earnings call, discussing financial performance and strategic updates. Key participants included CEO Adrian Mendes and CFO Sara Brien.

Portfolio Pulse from

November 15, 2024 | 6:30 pm

Perimeter Medical Imaging AI, Inc. will release its Q3 2024 financial results on November 14, 2024, followed by a webcast and conference call for a corporate update.

Portfolio Pulse from

November 08, 2024 | 1:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.